Article Details
Retrieved on: 2025-01-27 16:06:34
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a study on foralumab, a monoclonal antibody by Tiziana Life Sciences, showing promise in treating neurological diseases like multiple sclerosis by modulating immune pathways and reducing microglial inflammation, relevant to natural medicine.
Article found on: www.neurologylive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here